Diagnosis and Management of Stage 1 Hypertension

Definition and Classification

The American College of Cardiology/American Heart Association (ACC/AHA) defines Stage 1 hypertension as a blood pressure of 130-139/80-89 mmHg, with a 2-fold increase in cardiovascular disease risk compared to those with normal blood pressure (<120/80 mmHg) 1, 2
The European Society of Cardiology/European Society of Hypertension (ESC/ESH) defines this same blood pressure range as "high normal" blood pressure, not hypertension, with a threshold of ≥140/90 mmHg for hypertension 3, 4, 5

The diagnosis of hypertension requires an average of ≥2 readings obtained on ≥2 separate occasions, with confirmation using out-of-office blood pressure monitoring (home or ambulatory monitoring) strongly recommended to exclude white coat hypertension 1, 2, 3
White coat hypertension carries a cardiovascular disease risk similar to normal blood pressure and should not be treated as true hypertension 1, 6
The equivalent threshold for home blood pressure monitoring is ≥135/85 mmHg, and for 24-hour ambulatory monitoring, it is ≥130/80 mmHg 3, 4

Most patients with Stage 1 hypertension do not require immediate antihypertensive medication, with lifestyle modifications recommended as the initial approach 7, 6
The American College of Cardiology/American Heart Association recommends lifestyle modifications, including sodium restriction, weight loss, DASH diet, physical activity, and alcohol moderation, for all patients with Stage 1 hypertension 3, 1
Drug therapy is indicated immediately only for patients with high cardiovascular risk or evidence of target organ damage 1, 2, 3

Proper measurement technique requires 5 minutes of rest, seated position, empty bladder, correct cuff size on bare arm, arm supported at heart level, legs uncrossed with feet flat, back supported, and no talking 1, 6, 2
Common measurement errors include incorrect cuff size, cuff over clothing, unsupported arm, full bladder, legs crossed, and conversation during measurement, which can lead to over-diagnosis 7, 6, 2

The American College of Cardiology recommends that patients with stage 1 hypertension (BP 130-139/80-89 mmHg) who lack high-risk criteria should receive lifestyle modifications for 3-6 months before initiating drug therapy 8
High-risk criteria requiring immediate pharmacological therapy include age ≥65 years with systolic BP ≥130 mmHg, 10-year ASCVD risk ≥10%, diabetes mellitus, chronic kidney disease, known cardiovascular disease, and target organ damage 8, 9, 10

The American Heart Association recommends lifestyle modifications including sodium restriction to <1500 mg/day, DASH diet, weight loss if overweight, physical activity of 90-150 minutes/week, alcohol moderation, and potassium supplementation of 3500-5000 mg/day 8
ACE inhibitors like lisinopril are preferred first-line agents when specific comorbidities exist, such as diabetes with albuminuria, chronic kidney disease, heart failure, post-myocardial infarction, and stable ischemic heart disease 8

The American College of Cardiology recommends monthly follow-up for dose titration until BP is controlled, with a target BP of <130/80 mmHg 8, 9
If BP remains uncontrolled on lisinopril monotherapy, adding low-dose hydrochlorothiazide (12.5 mg) is recommended, based on guidelines from the Journal of the American College of Cardiology 11